Home / MAI Signal – Subscription Terms & Conditions
MAI Signal – Subscription Terms & Conditions
By subscribing to MAI Signal, you agree to the following plan-specific terms. These apply in addition to the MAI Legal Terms.
With MAI Signal you get:
Note: Results may sometimes contain inaccuracies, omissions, or errors.
The MAI Signal is €85.00 per month, billed annually at a total of €1,020.00 VAT not included.
Available payment methods:
The subscription automatically renews at the end of each term unless cancelled by the subscriber at least thirty (30) days in advance.
Fees may be updated upon prior notice. If the subscriber does not accept the revised fee, it may cancel the subscription before the effective date.
The subscriber shall be responsible for keeping its contact details up to date.
In the event of non-payment, a grace period of forty-eight (48) hours shall be granted. If payment is not received in the provider’s account within this period, the subscription will automatically switch to the Basic Plan, with reduced features. This clause is established pursuant to the freedom of contract recognized in the Spanish Commercial Code (arts. 1 et seq.) and Civil Code (art. 1,261), as well as Law 7/1998, of April 13, on General Conditions of Contracting, last updated 16/03/2019, ensuring clarity, precision, and transparency for the parties.
2026-02-23
The Backbone of Patient Safety: Navigating Aseptic Process Simulation and Equipment Qualification in Sterile Manufacturing.
See more
2026-02-17
From Random to Controlled: Navigating the Technical Evolution and Manufacturing Hurdles of Antibody-Drug Conjugates.
See more
2026-02-12
Beyond Capacity: How Smarter Science is Redefining Biologics Manufacturing
See more
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Accueil Sites Osny. Acquired in 2011, the Osny site specializes in the development and production of highly active solid pharmaceutical forms (hormonal and allergens). This 4,000 m2 pharmaceutical plant located 36 km northwest of Paris employs around a hundred people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), NMPA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP)
Markets: EMA (EU)
Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.
Activity: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING manufacturing
Uses: Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
If you have any questions or suggestions, click here. We will be happy to assist you.
